About
Basic Data Updated:
20 days agoThe business of R&D, manufacturing, and marketing of transdermal products for global markets is undertaken by Sparsha Pharma International Private Limited, as stated in its annual reports. The company's product range includes fen-touch, diclo-touch, artho-touch, and memory touch. It has been certified with GMP and its manufacturing unit spans over 20,000 sq ft. Within this, the production area occupies 14,000 sq ft while the quality control laboratory occupies 3,000 sq ft. In 2007, the company was incorporated and its registered office is situated in Hyderabad, Telangana.
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U24232TG2007PTC052719 |
| Company No. | 052719 |
| Company Classification | Private Limited Indian Non-Government Company |
| Incorporation Date | 12 Feb 2007 |
| Date of AGM | 16 Aug 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Hyderabad |
Financials of Sparsha Pharma International Private Limited
Sparsha Pharma International Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 47.43% increase. The company also saw a substantial improvement in profitability, with a 335.62% increase in profit. The company's net worth Soared by an impressive increase of 14.82%.
Corporate Structure
Unlock access to Sparsha Pharma International's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Sparsha Pharma International Private Limited
Unlock and access historical data on people associated with Sparsha Pharma International, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (2)
DV
Dange Veerapaneni
Managing DirectorAppointment Date: 11-Apr-2008
Status: Current
JS
J Sainathan
Company SecretaryAppointment Date: 27-Jan-2015
Status: Current
Board Members(4)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 10 Sep 2013 | ₹5.00 Cr | Open |
Technology Developement Board Creation Date: 06 May 2013 | ₹8.00 Cr | Satisfied |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sparsha Pharma International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sparsha Pharma International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
A.P.I.D.C. Venture Capital Private Limited
Active
34 years 8 months Bobba Venkatadri is a mutual person
Recent activity within the organization
Annual General Meeting
Sparsha Pharma International Private Limited last Annual general meeting of members was held on 16 Aug 2023 as per latest MCA records.
16 Aug 2023Balance Sheet
Sparsha Pharma International Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
31 Mar 2023Charges
A charge with Indian Overseas Bank of Rs. 5.00 cr registered on 10 Sep 2013 with Charge ID 10452407 was modified on 27 Oct 2022.
27 Oct 2022Director Appointment
Hiroyuki Kubo was appointed as a Director was appointed as a Director on 26 Mar 2018 & has been associated with this company since 6 years 1 month .
26 Mar 2018Charges
A charge registered on 06 May 2013 via Charge ID 10434203 with Technology Developement Board was fully satisfied on 10 Nov 2017.
10 Nov 2017
Frequently asked questions
What is the Incorporation or founding date of Sparsha Pharma International Private Limited?
